Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Cancer|November 29, 2023
Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?Austin D Williams, Karen Ruth, Saba S Shaikh, et al.
Kidney Cancer (Clifton, Va.)|February 12, 2019
Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial NephrectomyShreyas S Joshi, Karen Ruth, Marc C Smaldone, et al.
BJU International|August 26, 2010
Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160ValVeda N Giri, Karen Ruth, Lucinda Hughes, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implantThomas N Eade, Eric M Horwitz, Karen Ruth, et al.
Cancer|June 3, 2015
Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancerLora S Wang, Colin T Murphy, Karen Ruth, et al.
The Annals of Thoracic Surgery|December 3, 2014
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancerTalha Shaikh, Karen Ruth, Walter J Scott, et al.
Familial Cancer|February 20, 2013
Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trialSusan V Montgomery, Andrea M Barsevick, Brian L Egleston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Preoperative delays in the US Medicare population with breast cancerRichard J Bleicher, Karen Ruth, Elin R Sigurdson, et al.
Journal of Gastrointestinal Cancer|February 2, 2012
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research studyEfrat Dotan, Neal J Meropol, Barbara Burtness, et al.
Urology|July 4, 2012
Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancerLanea M M Keller, Mark K Buyyounouski, Dennis Sopka, et al.
Pageof 9